Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (1461 total)
-
Créateur: Stanley Perlman
Sujet: General
Type d'élément: Publication
Date de la dernière mise à jour: 2020-01-24
Description: For the third time in as many decades, a zoonotic coronavirus has crossed species to infect human populations. This virus, provisionally called 2019-nCoV, was first identified in Wuhan, China, in persons exposed to a seafood or wet market. -
Créateur: the mRNA-1273 Study Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-06
Description: Interim results from a phase 3 trial of the Moderna mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine indicated 94% efficacy in preventing coronavirus disease 2019 (Covid-19). -
Créateur: Manisty, Charlotte, Ashley D. Otter, Thomas A. Treibel, Áine McKnight, Daniel M. Altmann, Timothy Brooks, Mahdad Noursadeghi, Rosemary J. Boyton, Amanda Semper, and James C. Moon.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-25
Description: Rapid vaccine-induced population immunity is a key global strategy to control COVID-19. Vaccination programmes must maximise early impact, particularly with accelerated spread of new variants. -
Créateur: Zhao, Juanjuan, Quan Yuan, Haiyan Wang, Wei Liu, Xuejiao Liao, Yingying Su, Xin Wang, Jing Yuan, Tingdong Li, Jinxiu Li, Shen Qian, Congming Hong, Fuxiang Wang, Yingxia Liu, Zhaoqin Wang, Qing He, Zhiyong Li, Bin He, Tianying Zhang, Shengxiang Ge,…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-03-03
Description: Summary Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patient remains largely unknown, and the clinical values of antibody testing have not been fully demonstrated. Methods A total of 173… -
Créateur: the Oxford University Hospitals Staff Testing Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-11
Description: The relationship between the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains unclear.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: Association of Public Health Laboratories (APHL)
Sujet: Laboratory
Type d'élément: Liste de contrôle
Date de la dernière mise à jour: 2015-04
Description: APHL A Biosafety Checklist: Developing A Culture of BiosafetyExample only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: Association of Public Health Laboratories (APHL)
Sujet: Laboratory
Type d'élément: Guide
Date de la dernière mise à jour: 2016-05-05
Description: APHL Laboratory Risk Assessment Best Practices TemplatesExample only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: Association of Public Health Laboratories (APHL)
Sujet: Laboratory
Type d'élément: Guide
Date de la dernière mise à jour: 2014
Description: Template for Public Health Laboratory Risk Assessment for Ebola Virus Disease (EVD) TestingExample only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: APIC and NETEC
Sujet: Infection Control
Type d'élément: Webinaire
Date de la dernière mise à jour: 2024-08-21
Description: Angela M. Vasa, MSN, RN, Carrie Billman, MHPE, RN, CIC, Kari Love, RN, PhDc, CIC, FAPIC, and Pam Farrare-Wilmore, MT(ASCP), CIC Join NETEC and APIC for an in-depth exploration of the latest infection control requirements established by the Joint…